Form 4: Mirum Pharmaceuticals Executive Sells Shares
Insider Transaction (Form 4)
Jolanda Howe, SVP, GLOBAL CONTROLLER of Mirum Pharmaceuticals, Inc., sold 40,000 shares of common stock on August 18, 2026 for $100.00 per share.
Summary
- Option exercise/conversion: acquired 40,000 Common Stock at $6.27 ($250,800) on August 18, 2026; holds 41,274 after (Direct).
- Open-market sale: disposed of 40,000 Common Stock at $100.00 ($4,000,000) on August 18, 2026; holds 1,274 after (Direct).
- Option exercise/conversion: disposed of 40,000 Employee Stock Option (right to buy) on August 18, 2026 (Direct).
Sentiment
Score: 3
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $4,000,000 of stock on the open market.
Insider Transactions
Jolanda Howe — Officer (SVP, GLOBAL CONTROLLER)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Option exercise/conversion | Common Stock | 40,000 | $6 | $250.8K | 41,274 |
| 2026-08-18 | Open-market sale | Common Stock | 40,000 | $100 | $4.0M | 1,274 |
| 2026-08-18 | Option exercise/conversion | Employee Stock Option (right to buy) | 40,000 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Option exercise/conversion (40,000 shares) |
| 2026-08-18 | Open-market sale (40,000 shares) |
| 2026-08-18 | Option exercise/conversion (40,000 shares) |
Keywords
insider transaction, Form 4, MIRM, Mirum Pharmaceuticals, Inc., bearish, Jolanda Howe
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.